Greenwich LifeSciences GLSI
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 24.02 | 5 | -201.21 | -6 | -67.82 | 11 |
| 2025Q4 | 21.01 | 0 | -624.35 | -8 | -158.7 | 6 |
| 2025Q3 | 9.95 | 2 | -229.14 | -4 | -119.79 | 4 |
| 2025Q2 | 9.07 | 1 | -329.99 | -5 | -154.49 | 3 |
| 2025Q1 | 9.54 | 1 | -142.75 | -3 | -80.2 | 3 |
| 2024Q4 | 11.23 | 3 | -213.92 | -8 | -162.11 | 4 |
| 2024Q3 | 14.37 | 5 | -49.16 | -3 | -40.89 | 6 |
| 2024Q2 | 17.26 | 6 | -47.42 | -3 | -40.93 | 7 |
| 2024Q1 | 19.94 | 5 | -41.84 | -2 | -39.55 | 6 |
| 2023Q4 | 10.52 | 7 | -35.32 | -3 | -34.03 | 7 |
| 2023Q3 | 8.84 | 9 | -24.53 | -2 | -23.8 | 9 |
| 2023Q2 | 9.65 | 11 | -14.58 | -2 | -14.24 | 11 |
| 2023Q1 | 13.79 | 12 | -17.07 | -2 | -16.73 | 12 |
| 2022Q4 | 15.2 | 13 | -19.5 | -3 | -19.17 | 13 |
| 2022Q3 | 9.1 | 15 | -14.32 | -2 | -14.12 | 16 |
| 2022Q2 | 8.47 | 17 | -4.09 | -1 | -4.04 | 17 |
| 2022Q1 | 19.62 | 20 | -8.5 | -2 | -8.39 | 20 |
| 2021Q4 | 24.33 | 27 | -8.54 | -2 | -8.41 | 27 |
| 2021Q3 | 39.07 | 28 | -3 | -1 | -2.94 | 29 |
| 2021Q2 | 44.94 | 29 | -2.55 | -1 | -2.49 | 30 |